Avtozma 162mg/0.9 ml, solution injectable en seringue préremplie

7680698540021 CH-69854 Lösung

Associated product:

AVTOZMA 162mg/0.9 ml sol inj 162 mg 4 pce

No image available

Article details

Package size
4
Selling units
4
Measure
Fertigspritze(n)
Galenic form
Lösung
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
18/04/2026
Patient information leaflet
Français
18/04/2026
Patient information leaflet
Italien
18/04/2026

Detailed composition

Substance Quantity Type Category
tocilizumabum
162.0 MG Substance Wirkstoff (Principe actif)
histidinum
- Substance HNIDK
histidini hydrochloridum monohydricum
- Substance HNIDK
methioninum
- Substance HNIDK
threoninum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK

Reimbursement information

Public price
CHF 697.15
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/04/2026

Authorization holder

IQONE HEALTHCARE SWITZERLAND

1290 Versoix

Authorization information

Swissmedic authorization number
69854
Drug name
Avtozma, solution injectable en seringue préremplie
Galenic form
INLFS
ATC Code
L04AC07
Authorization status
Z
Dispensing category
A
First authorization
20/06/2025
Authorization expiration date
19/06/2030
IT Number
07.15.0.
Domain
Human medicine

Package details

Description (FR)
AVTOZMA 162mg/0.9 ml sol inj 162 mg 4 pce
Description (DE)
AVTOZMA 162mg/0.9 ml Inj Lös 162 mg 4 Stk
Market launch
01/04/2026
Narcotic (BTM)
No

Other package sizes (1)

None
1 FESP
GTIN: None
Not in V1
Buy us a coffee Explore the data